NCT02401529

Brief Summary

This study aims to evaluate the effect of postoperative systemic rapid onset and short acting dexamethasone followed by a tapering dose of oral prednisolone on post-tonsillectomy morbidities. Half of the patients who comply with the inclusion criteria were selected to receive a single postoperative dose of intravenous dexamethasone followed by oral steroids; the second group received placebo.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2 postoperative-pain

Timeline
Completed

Started Jan 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 21, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 30, 2015

Completed
4 months until next milestone

Results Posted

Study results publicly available

July 15, 2015

Completed
Last Updated

July 15, 2015

Status Verified

June 1, 2015

Enrollment Period

1.2 years

First QC Date

March 21, 2015

Results QC Date

May 6, 2015

Last Update Submit

June 20, 2015

Conditions

Keywords

DexamethasonePrednisoloneTonsillectomy NauseaPain, PostoperativePostoperative Nausea and VomitingRandomized controlled trialPost-tonsillectomy paindelayed feeding

Outcome Measures

Primary Outcomes (7)

  • Maximum Severity of Post-operative Pain

    5 grades (pain free, low disability and low intensity, low disability and high intensity, high disability and moderate intensity, high disability and severly limiting)

    The severest pain grade felt within a week

  • Duration of Post-operative Pain

    4 selections (1 day, 2 days, 3 days, if more specify)

    number of days at which pain was experienced within the the 1st sevn days post -surgery

  • Occurence of Post-operative Nausea

    Postoperative nausea occurence (yes, no)

    7 days

  • Onset of Post-operative Nausea

    Postoperative nausea onset (no nausea, immediate, 1st day, 2nd day, 3rd day, 4th day, 5th day, 6th day, 7th day)

    onset of 1st ocurence of nausea attack within the 1st week post-surgery

  • Duration of Post-operative Nausea

    Postoperative nausea duration (no nausea,1 day, 2 days, 3 days, 4 days, if more specify)

    7 days

  • Occurence of Postoperative Vomiting

    Postoperative vomiting occurrence (yes, no)

    7 days

  • Total Number of Post-operative Vomiting Episodes

    Postoperative vomiting number of attacks (no vomiting,1, 2, 3, if more specify)

    total number of post-operative vomiting episodes which were experienced within the 1st week post-surgery

Secondary Outcomes (3)

  • Onset of 1st Post-operative Oral Intake

    Onset of 1st post-operative oral intake recorded within the 1st 3days post-surgery

  • Average Amount of Meal Per Day

    3 days

  • Average Frequency of Meals Per Day

    average number of meals consumed per day for the 1st three days post-surgery

Study Arms (2)

IV dexamethasone and oral Prednisolone

EXPERIMENTAL

Single dose of intravenous dexamethasone given immediately following surgery (0.15 mg/kg), followed by oral Prednisolone (0.25mg/kg/day for 7 days then tapering for next 7 days) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours).

Drug: IV dexamethasoneDrug: Oral prednisoloneDrug: Paracetamol

Placebo

ACTIVE COMPARATOR

Placebo (IV saline) and paracetamol (acetaminophen 15 mg/kg/dose every 6 hours).

Drug: ParacetamolDrug: IV saline

Interventions

0.15 mg/kg

Also known as: Decadron
IV dexamethasone and oral Prednisolone

0.25mg/kg/day for 7 days then tapering for next 7 days

Also known as: Predosone
IV dexamethasone and oral Prednisolone

acetaminophen 15 mg/kg/dose every 6 hours

Also known as: Adol
IV dexamethasone and oral PrednisolonePlacebo

IV saline

Also known as: Saline
Placebo

Eligibility Criteria

Age5 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients in the waiting list for tonsillectomy under general anesthesia who accepted to participate in the study.

You may not qualify if:

  • Patients who are allergic to steroids or those who have medical conditions which contraindicate the use of steroid i.e diabetes mellitus, gastritis, or hypertension and those who were on exogenous steroid supplements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (25)

  • Elhakim M, Ali NM, Rashed I, Riad MK, Refat M. Dexamethasone reduces postoperative vomiting and pain after pediatric tonsillectomy. Can J Anaesth. 2003 Apr;50(4):392-7. doi: 10.1007/BF03021038. English, French.

    PMID: 12670818BACKGROUND
  • Weimert TA, Babyak JW, Richter HJ. Electrodissection tonsillectomy. Arch Otolaryngol Head Neck Surg. 1990 Feb;116(2):186-8. doi: 10.1001/archotol.1990.01870020062016.

    PMID: 2297411BACKGROUND
  • Leach J, Manning S, Schaefer S. Comparison of two methods of tonsillectomy. Laryngoscope. 1993 Jun;103(6):619-22. doi: 10.1288/00005537-199306000-00008.

    PMID: 8502095BACKGROUND
  • Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist. 2007 Sep;12(9):1143-50. doi: 10.1634/theoncologist.12-9-1143.

    PMID: 17914084BACKGROUND
  • Baxendale BR, Vater M, Lavery KM. Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia. 1993 Nov;48(11):961-4. doi: 10.1111/j.1365-2044.1993.tb07474.x.

    PMID: 8250191BACKGROUND
  • Browning GG. Prophylactic steroids and/or antibiotics to reduce post-tonsillectomy morbidity: a yet unanswered conundrum. Clin Otolaryngol. 2010 Oct;35(5):417. doi: 10.1111/j.1749-4486.2010.02211.x. No abstract available.

    PMID: 21108754BACKGROUND
  • Hermans V, De Pooter F, De Groote F, De Hert S, Van der Linden P. Effect of dexamethasone on nausea, vomiting, and pain in paediatric tonsillectomy. Br J Anaesth. 2012 Sep;109(3):427-31. doi: 10.1093/bja/aes249.

    PMID: 22879656BACKGROUND
  • Park SK, Kim J, Kim JM, Yeon JY, Shim WS, Lee DW. Effects of oral prednisolone on recovery after tonsillectomy. Laryngoscope. 2015 Jan;125(1):111-7. doi: 10.1002/lary.24958. Epub 2014 Oct 7.

    PMID: 25291409BACKGROUND
  • Andersen R, Krohg K. Pain as a major cause of postoperative nausea. Can Anaesth Soc J. 1976 Jul;23(4):366-9. doi: 10.1007/BF03005916.

    PMID: 7347BACKGROUND
  • McKean S, Kochilas X, Kelleher R, Dockery M. Use of intravenous steroids at induction of anaesthesia for adult tonsillectomy to reduce post-operative nausea and vomiting and pain: a double-blind randomized controlled trial. Clin Otolaryngol. 2006 Feb;31(1):36-40. doi: 10.1111/j.1749-4486.2006.01141.x.

    PMID: 16441800BACKGROUND
  • Beirne OR, Hollander B. The effect of methylprednisolone on pain, trismus, and swelling after removal of third molars. Oral Surg Oral Med Oral Pathol. 1986 Feb;61(2):134-8. doi: 10.1016/0030-4220(86)90173-8.

    PMID: 3457335BACKGROUND
  • Campbell WI, Kendrick RW. Postoperative dental pain--a comparative study of anti-inflammatory and analgesic agents. Ulster Med J. 1991 Apr;60(1):39-43.

    PMID: 1853495BACKGROUND
  • Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000 Jan;90(1):186-94. doi: 10.1097/00000539-200001000-00038.

    PMID: 10625002BACKGROUND
  • Alexander TH, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE, Harris JP. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol. 2009 Jun;30(4):443-8. doi: 10.1097/MAO.0b013e3181a52773.

    PMID: 19395984BACKGROUND
  • Thomas S, Beevi S. Epidural dexamethasone reduces postoperative pain and analgesic requirements. Can J Anaesth. 2006 Sep;53(9):899-905. doi: 10.1007/BF03022833.

    PMID: 16960268BACKGROUND
  • Rich WM, Abdulhayoglu G, DiSaia PJ. Methylprednisolone as an antiemetic during cancer chemotherapy--a pilot study. Gynecol Oncol. 1980 Apr;9(2):193-8. doi: 10.1016/0090-8258(80)90027-x. No abstract available.

    PMID: 7189499BACKGROUND
  • Fredrikson M, Hursti T, Furst CJ, Steineck G, Borjeson S, Wikblom M, Peterson C. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer. 1992 May;65(5):779-80. doi: 10.1038/bjc.1992.165. No abstract available.

    PMID: 1586608BACKGROUND
  • Harris AL. Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet. 1982 Mar 27;1(8274):714-6. doi: 10.1016/s0140-6736(82)92625-3. No abstract available.

    PMID: 6122010BACKGROUND
  • Splinter W, Roberts DJ. Prophylaxis for vomiting by children after tonsillectomy: dexamethasone versus perphenazine. Anesth Analg. 1997 Sep;85(3):534-7. doi: 10.1097/00000539-199709000-00010.

    PMID: 9296405BACKGROUND
  • Ahmad S, De Oliveira GS Jr, Fitzgerald PC, McCarthy RJ. The effect of intravenous dexamethasone and lidocaine on propofol-induced vascular pain: a randomized double-blinded placebo-controlled trial. Pain Res Treat. 2013;2013:734531. doi: 10.1155/2013/734531. Epub 2013 Jul 15.

    PMID: 23956857BACKGROUND
  • Fazel MR, Yegane-Moghaddam A, Forghani Z, Aghadoost D, Mahdian M, Fakharian E. The effect of dexamethasone on postoperative vomiting and oral intake after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2007 Aug;71(8):1235-8. doi: 10.1016/j.ijporl.2007.04.015. Epub 2007 Jun 1.

    PMID: 17544156BACKGROUND
  • Hashmi MA, Ahmed A, Aslam S, Mubeen M. Post-tonsillectomy pain and vomiting:role of pre-operative steroids. J Coll Physicians Surg Pak. 2012 Aug;22(8):505-9.

    PMID: 22868016BACKGROUND
  • Kaan MN, Odabasi O, Gezer E, Daldal A. The effect of preoperative dexamethasone on early oral intake, vomiting and pain after tonsillectomy. Int J Pediatr Otorhinolaryngol. 2006 Jan;70(1):73-9. doi: 10.1016/j.ijporl.2005.05.013. Epub 2005 Jun 24.

    PMID: 15979735BACKGROUND
  • Steward DL, Welge JA, Myer CM. Steroids for improving recovery following tonsillectomy in children. Cochrane Database Syst Rev. 2003;(1):CD003997. doi: 10.1002/14651858.CD003997.

    PMID: 12535500BACKGROUND
  • Scarlett M, Tennant I, Ehikhametalor K, Nelson M. Vomiting post tonsillectomy at the University Hospital of the West Indies. West Indian Med J. 2005 Jan;54(1):59-64. doi: 10.1590/s0043-31442005000100012.

    PMID: 15892392BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativePostoperative Nausea and Vomiting

Interventions

DexamethasoneCalcium DobesilatePrednisoloneAcetaminophenSodium Chloride

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNauseaSigns and Symptoms, DigestiveVomiting

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedBenzenesulfonatesBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsArylsulfonatesArylsulfonic AcidsSulfonic AcidsSulfur AcidsSulfur CompoundsAcetanilidesAnilidesAmidesAniline CompoundsAminesChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Results Point of Contact

Title
Dr Faris Ahmed Bahammam
Organization
King Fahd General Hospital

Study Officials

  • Dr.Faris A Bahammam, MD

    ORL and Head & Neck Surgeon

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 21, 2015

First Posted

March 30, 2015

Study Start

January 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

July 15, 2015

Results First Posted

July 15, 2015

Record last verified: 2015-06